Vitamin D3 for Life

Live Enlightened

Article

Renal and Intestinal CYP24A1 Regulation: Full Evidence Review

Previous related pagePharmacokinetics of a single, large dose of cholecalciferol: Full StudyNext related pageRenal and Intestinal CYP24A1 Regulation: Study Summary
Study at a glance

How did researchers test vitamin D breakdown in mice?

Researchers changed mice so that an enzyme called CYP24A1 no longer worked throughout the body, in the kidneys or in the intestine. This enzyme helps break down vitamin D compounds. The researchers checked where its function was lost, then compared blood measurements and tissue responses during normal feeding, high-calcium feeding and experimentally caused kidney disease.

Did losing the vitamin D breakdown enzyme affect the kidneys and intestine differently?

Losing the enzyme in the kidneys raised active vitamin D and its starting compound in the blood. Blood calcium rose mildly, while a calcium-regulating hormone called PTH fell. Losing the enzyme in the intestine increased local vitamin D signals without the same blood changes. During high-calcium feeding, these mice had lower PTH and more calcium in urine. The researchers interpreted this as evidence of greater calcium absorption, rather than directly measuring absorption.

What changed when the mice had kidney disease?

In male mice with experimentally caused kidney disease, losing intestinal CYP24A1 reduced the rise in PTH and another mineral-regulating hormone, FGF23. Blood calcium and phosphate did not rise, and measured kidney injury did not worsen. However, FGF23 moved in different directions during high-calcium feeding and kidney disease. The result therefore does not show one response that applies in every setting.

Do these mouse experiments establish a treatment for people?

These were genetic experiments in mice, not treatment trials in people. They do not establish a safe medicine dose or long-term benefits. Early findings from mice that lost the kidney enzyme during kidney disease linked this loss to severely high blood calcium, worse illness and deaths. Reducing vitamin D breakdown is therefore not always beneficial. The affected tissue and the conditions matter.

Read the full article below ↓

CYP24A1 helps control vitamin D activity by metabolising 25 hydroxyvitamin D and calcitriol. Fuchs and colleagues tested whether that control has the same physiological importance in every tissue. By deleting Cyp24a1 globally, in the kidney, or in the intestine of mice, they created a direct comparison between systemic and local vitamin D regulation. Renal loss changed circulating vitamin D metabolites and whole body mineral feedback. Intestinal loss increased local vitamin D signalling without reproducing the same systemic metabolite pattern.

This distinction belongs within the wider physiology described in Vitamin D Clearance and Degradation. CYP24A1 is not simply a disposal enzyme. Its effect depends on where it operates, which vitamin D metabolites are available, and whether its activity contributes mainly to local signalling or to the circulating endocrine pool.

The study tested whether renal and intestinal CYP24A1 control different physiological scales

The authors predicted that loss of renal CYP24A1 would resemble global loss because the kidney is a major regulated source of circulating calcitriol. Circulating 1,25D was therefore expected to rise, vitamin D receptor activity to increase across tissues, serum calcium to rise and PTH to fall.

By contrast, intestinal deletion could increase vitamin D activity inside intestinal cells without necessarily increasing circulating 1,25D. This distinction reflects the broader physiology described in How Cellular Vitamin D Metabolism Differs Between Tissues.

The study also explored whether greater local intestinal vitamin D activity could influence calcium handling and suppress secondary hyperparathyroidism during chronic kidney disease without causing the systemic hypercalcaemia associated with loss of renal CYP24A1. This remained an experimental mouse question rather than a human treatment trial.

Three deletion models made tissue location the experimental variable

The investigators created a floxed Cyp24a1 allele by placing loxP sites around exon 5. They then used separate Cre systems for global deletion, nephron and kidney deletion, and intestinal epithelial deletion. Cre negative littermates received the same experimental treatments and served as controls.

The exon choice was important. Exon 5 contributes to the substrate channel architecture of CYP24A1. Modelling predicted that its removal would severely disrupt regions required for catalytic function, electron transfer, substrate positioning and mitochondrial targeting. The investigators therefore did not rely on genetic recombination alone. They also tested whether CYP24A1 function had actually been lost.

The wider relationship between vitamin D activation and degradation is explained in Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1).

The models were checked for tissue specificity and loss of enzyme function

Tissue specificity was tested using complementary methods. An in situ hybridisation probe targeting the floxed exon helped identify cells that escaped recombination. A Rosa26 tdTomato reporter confirmed strong recombination in intestinal epithelium without corresponding kidney recombination. These controls were important because an apparent intestinal phenotype would be difficult to interpret if renal CYP24A1 had also been affected.

Functional testing strengthened the model. Primary proximal tubule cells from mice lacking renal CYP24A1 were exposed to 7 nM 25D for 12 hours. Control cultures increased 24,25D in the medium, whereas CYP24A1 deficient cultures did not.

In the global knockout model, two calcitriol injections of 2.5 μg/kg given 48 hours apart produced larger rises in serum calcium, 1,25D and FGF23 than in controls. These experiments showed that the genetic manipulation materially impaired vitamin D catabolism rather than merely changing an RNA marker.

The underlying catabolic chemistry is examined in greater depth in Cellular Degradation and Feedback Regulation of Vitamin D: Full Evidence Review.

Calcitriol strongly induced CYP24A1 in both kidney and intestine

Before comparing knockout phenotypes, the investigators examined where Cyp24a1 responds to calcitriol. Six hours after a 10 μg/kg calcitriol injection, RNAscope showed marked induction in renal proximal tubules across the cortex. Basal intestinal expression was very low, but calcitriol strongly induced Cyp24a1 across intestinal epithelial cells.

The shared response does not mean that the enzyme performs an identical physiological job in both organs. Expression and physiological function are different questions. The deletion experiments provided the causal test.

Renal deletion reproduced much of the systemic effect of global deletion

Adult mice were followed for 12 weeks on a standard diet containing 0.8% calcium. Global deletion increased circulating 1,25D and 25D, reduced 24,25D, increased the 1,25D to 24,25D ratio, suppressed PTH and increased FGF23.

Renal deletion produced a closely related systemic profile. The mice developed mild hypercalcaemia, increased circulating 1,25D and 25D, reduced 24,25D and lower PTH. The similarity between global and renal deletion supports a major renal contribution to systemic CYP24A1 control.

This result complements the broader renal physiology in Vitamin D and Kidneys. The Fuchs experiment adds causal evidence that changing renal CYP24A1 alters the circulating vitamin D system.

Renal knockout mice had a modest rise in blood urea nitrogen but unchanged creatinine and no histological evidence of kidney injury under the standard diet experiment. The authors interpreted the blood urea nitrogen result cautiously, including the possibility that mild hypercalcaemia produced a prerenal effect rather than structural kidney damage.

Intestinal deletion increased local vitamin D signalling without the same circulating changes

The intestinal knockout behaved differently. Circulating vitamin D metabolites, calcium, phosphate and the major systemic mineral markers did not reproduce the pattern seen after global or renal deletion. Yet qPCR showed significantly increased intestinal vitamin D receptor target gene expression while renal target genes remained unchanged.

This was the clearest separation between local activity and circulating status. Removing intestinal CYP24A1 increased vitamin D signalling within that tissue even though circulating 1,25D did not rise. The result directly illustrates the physiology discussed in Vitamin D Metabolism at the Cellular Level.

It also connects with Vitamin D and Intracrine Activity, because local vitamin D activity can be generated, used and degraded within a tissue without every change appearing in the circulating hormone concentration.

A calcium challenge revealed a physiological effect of local intestinal signalling

The investigators then used a diet containing 2.0% calcium for 12 weeks. Global and renal knockout mice developed or worsened hypercalcaemia and retained the systemic pattern of high 1,25D and 25D, elevated FGF23 and suppressed PTH. Intestinal knockout mice again did not develop the same systemic vitamin D phenotype.

Nevertheless, PTH was significantly lower in the intestinal knockout despite unchanged serum calcium, phosphate, 1,25D and 25D. Urinary calcium excretion increased. In the reported regression analysis, the urine calcium to creatinine ratio was 0.72 units higher for a given serum calcium in intestinal knockout mice than in controls, with a 95% confidence interval from 0.18 to 1.26 and P = 0.01.

The authors interpreted this combination as evidence that greater local intestinal vitamin D activity increased calcium absorption. The relationship between vitamin D and calcium handling is described more broadly in Vitamin D Calcium Physiology.

The chronic kidney disease experiment tested whether local intestinal effects alter endocrine feedback

The chronic kidney disease experiment used male intestinal knockout mice because adenine nephropathy has known sex differences. Mice received a 0.2% adenine diet supplemented with 1% calcium and no vitamin D for two weeks. Histology, glomerular filtration rate, blood urea nitrogen and markers of kidney injury and fibrosis confirmed kidney damage.

Kidney injury severity did not differ between intestinal knockout and control mice on the disease diet. This made the endocrine comparison more interpretable because lower PTH could not simply be explained by milder kidney injury.

Against that matched background, intestinal Cyp24a1 deletion significantly attenuated the rises in PTH and FGF23. Serum calcium and phosphate did not increase, and kidney damage did not worsen. The result connects with the mineral feedback described in Vitamin D and Phosphate Regulation.

FGF23 changed in different directions under different experimental conditions

The FGF23 response prevents a simple interpretation. In intestinal knockout mice with intact kidneys challenged with high calcium, FGF23 increased modestly. In the adenine chronic kidney disease experiment, FGF23 was significantly lower than in disease controls. PTH was lower in both settings.

The authors did not claim that this difference was resolved. Reduced PTH could contribute to lower FGF23 during chronic kidney disease, but that explanation is incomplete because PTH was also lower during the calcium challenge when FGF23 moved upward. The evidence therefore does not support a general claim that intestinal CYP24A1 always changes FGF23 in one direction.

The causal strength comes from changing CYP24A1 function in defined tissues

The study combines several causal layers. It engineered loss of CYP24A1 function, verified where recombination occurred, demonstrated impaired metabolite production, compared global with organ specific deletion, and measured systemic metabolites, endocrine hormones and tissue vitamin D receptor response genes.

The strongest inference concerns physiological scale. In these mouse models, renal CYP24A1 materially controls circulating vitamin D exposure, while intestinal CYP24A1 can constrain local vitamin D signalling and influence calcium and PTH physiology without requiring a matching increase in circulating 1,25D.

What the study does not establish

The experiment does not establish a human treatment effect, a safe CYP24A1 inhibitor dose, or the long term skeletal and cardiovascular consequences of selectively reducing intestinal CYP24A1. The intervention was genetic and tissue specific in mice. Pharmacological inhibition in humans could have different selectivity, exposure and unintended effects.

The study also does not establish that intestinal CYP24A1 is irrelevant to systemic physiology under every condition. Different diets, disease states, developmental stages or degrees of enzyme inhibition could change the balance between local and systemic effects.

Preliminary renal deletion during chronic kidney disease also warns against assuming that reducing CYP24A1 is uniformly beneficial. Severe hypercalcaemia was associated with worse disease and mortality in that setting. Tissue location is therefore central to the biological consequence of altering the enzyme.

Primary source and publication details

Fuchs MAA, Grabner A, Shi M, et al.

Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice.

Journal of Clinical Investigation. 2025;135(4):e179882.

PMID: 39688907

PMCID: PMC11827884

DOI: 10.1172/JCI179882

View the verified primary source

Related reading

Original sources